Winning Health Technology Group Co., Ltd. (SHE:300253)
China flag China · Delayed Price · Currency is CNY
9.54
+0.26 (2.80%)
May 8, 2026, 3:04 PM CST

SHE:300253 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,1592,1062,7823,1613,0912,749
Other Revenue
0.010.010.442.471.380.94
2,1592,1062,7823,1633,0932,750
Revenue Growth (YoY)
-18.01%-24.30%-12.05%2.28%12.46%21.34%
Cost of Revenue
1,4641,4151,6231,7411,7421,476
Gross Profit
694.86691.431,1591,4231,3511,275
Selling, General & Admin
504.4497.8545.37653.83707.67585.95
Research & Development
362.81333.54264.63333.3313.77255.67
Other Operating Expenses
-44.43-50.99-107.76-99.2825.8-79.54
Operating Expenses
966.6915.62888.611,0271,282995.35
Operating Income
-271.74-224.19270.25395.2869.54279.34
Interest Expense
-69.47-68.6-66.76-64.05-59.63-46.68
Interest & Investment Income
7.856.9210.1443.0920.6211.8
Currency Exchange Gain (Loss)
----0.01-0
Other Non Operating Income (Expenses)
-12.24-13.14-5.320.78-14.25-22.38
EBT Excluding Unusual Items
-345.6-299.01208.31375.0916.28222.08
Impairment of Goodwill
-87.69-87.69-63.64-6.6-22.94-
Gain (Loss) on Sale of Investments
-67.36-66.37-76.83-50.46-90.56116.51
Gain (Loss) on Sale of Assets
3.053.05-0.28-0.43-0.520.18
Asset Writedown
19.92-0.28-0.09-0.05-0.31-0.31
Legal Settlements
----0.26--
Other Unusual Items
22.377.8319.4923.46136.634.72
Pretax Income
-455.31-442.4886.96340.7538.54373.17
Income Tax Expense
-73.14-58.336.8923.1323.7819.43
Earnings From Continuing Operations
-382.17-384.1750.07317.6214.76353.73
Minority Interest in Earnings
17.0310.2937.8340.3493.8824.44
Net Income
-365.14-373.8887.89357.96108.64378.17
Net Income to Common
-365.14-373.8887.89357.96108.64378.17
Net Income Growth
---75.45%229.49%-71.27%-22.99%
Shares Outstanding (Basic)
2,2162,2102,1542,1472,1392,143
Shares Outstanding (Diluted)
2,2162,2102,1602,1952,1432,147
Shares Change (YoY)
2.05%2.32%-1.60%2.42%-0.22%0.44%
EPS (Basic)
-0.16-0.170.040.170.050.18
EPS (Diluted)
-0.16-0.170.040.160.050.18
EPS Growth
---75.05%221.70%-71.21%-23.34%
Free Cash Flow
351.38335.01101.71-128.53-223.2681.83
Free Cash Flow Per Share
0.160.150.05-0.06-0.100.04
Dividend Per Share
--0.0150.0200.0100.020
Dividend Growth
---25.00%100.00%-50.00%-20.00%
Gross Margin
32.19%32.83%41.65%44.97%43.69%46.35%
Operating Margin
-12.59%-10.64%9.71%12.50%2.25%10.16%
Profit Margin
-16.91%-17.75%3.16%11.32%3.51%13.75%
Free Cash Flow Margin
16.28%15.91%3.66%-4.06%-7.22%2.97%
EBITDA
-252.27-204.03293.17417.0690.9299.2
EBITDA Margin
-11.69%-9.69%10.54%13.18%2.94%10.88%
D&A For EBITDA
19.4720.1622.9121.7721.3519.86
EBIT
-271.74-224.19270.25395.2869.54279.34
EBIT Margin
-12.59%-10.64%9.71%12.50%2.25%10.16%
Effective Tax Rate
--42.42%6.79%61.71%5.21%
Revenue as Reported
2,1592,1062,7823,1633,0932,750
Source: S&P Global Market Intelligence. Standard template. Financial Sources.